Perindopril — CAS 107133-36-8

Perindopril is a long-acting ACE (Angiotensin-Converting Enzyme) inhibitor used in the treatment of hypertension, heart failure, and cardiovascular risk reduction. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. As a prodrug, Perindopril is hydrolyzed in vivo to its active metabolite Perindoprilat, which inhibits ACE and reduces angiotensin II-mediated vasoconstriction, lowering blood pressure effectively.

• Essential hypertension management — first-line ACE inhibitor therapy
• Congestive heart failure treatment and symptom management
• Cardiovascular risk reduction in stable coronary artery disease
• Nephroprotection in diabetic nephropathy

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support